SCHEMBL4849002

SCHEMBL4849002

Nc1ccc(Oc2cccc3c(Oc4ccc(N)c(O)c4)cccc23)cc1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.47
RCE1 Q9Y256 1/20 0.47
ALDH1A1 P00352 2/20 0.41
CYP3A4 P08684 1/20 0.41
ALOX15 P16050 1/20 0.41
HSD17B10 Q99714 1/20 0.41
NR4A1 P22736 1/20 0.41
F10 P00742 1/20 0.40
MAPT P10636 4/20 0.39
RAB9A P51151 2/20 0.39
NPC1 O15118 1/20 0.39
TSHR P16473 1/20 0.39
MMP2 P08253 1/20 0.39
MMP14 P50281 1/20 0.39
TLR4 O00206 1/20 0.39
HDAC3 O15379 1/20 0.38
IDO1 P14902 1/20 0.38
EP300 Q09472 1/20 0.38
KAT2B Q92831 1/20 0.38
KAT8 Q9H7Z6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL716943 0.87 GAA (0.52) GAARCE1ALDH1A1CYP3A4ALOX15
SCHEMBL10729691 0.83 NR4A1 (0.61) GAARCE1ALDH1A1CYP3A4HSD17B10
SCHEMBL2747297 0.83 GAA (0.38) GAARCE1ALDH1A1CYP3A4HSD17B10
SCHEMBL29718932 0.81 MEN1 (0.57) GAAALDH1A1CYP3A4ALOX15HSD17B10
SCHEMBL1553835 0.81 MEN1 (0.57) GAAALDH1A1CYP3A4ALOX15HSD17B10
SCHEMBL436522 0.80 NR4A1 (0.61) GAAALDH1A1CYP3A4ALOX15HSD17B10
SCHEMBL30040301 0.80 NR4A1 (0.61) GAAALDH1A1CYP3A4ALOX15HSD17B10
SCHEMBL4841637 0.80 GAA (0.53) GAARCE1ALDH1A1CYP3A4ALOX15
SCHEMBL11224092 0.79 GAA (0.45) GAARCE1ALDH1A1CYP3A4F10
SCHEMBL2747475 0.79 GAA (0.49) GAARCE1ALDH1A1F10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7365231-B2 Compound with antitumor activity and preparation method therefor NATIONAL TAIWAN UNIVERSITY OF SCIENCE & TECHNOLOGY (TW) 2008-04-29 US disclosed
US-20060241187-A1 Compound with antitumor activity and preparation method therefor NATIONAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY (TW) 2006-10-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060241187-A1 Compound with antitumor activity and preparation method therefor WEE1, WEE2, CYP51A1 GAA 682/4885RCE1 212/4885ALDH1A1 206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.